SMTL ID : 6dbn.1

Jak1 with compound 23

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

monomer

Ligands

1 x G4J: [(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone(Non-covalent)

G4J.1: 23 residues within 4Å: Chain A: L.43, G.44, E.45, G.46, G.49, K.50, V.51, A.68, K.70, V.100, M.118, E.119, F.120, L.121, P.122, S.123, G.124, E.128, R.169, N.170, L.172, G.182, D.183 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.51, A:A.68, A:L.172, A:L.172, A:D.183 Hydrogen bonds: A:R.41, A:L.121, A:L.121 Halogen bonds: A:G.44

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fensome, A. et al., Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841). J. Med. Chem. (2018)

Release Date

2018-08-29

Peptides

Tyrosine-protein kinase JAK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK1

Related Entries With Identical Sequence